Evaluating the causal association between type 2 diabetes and Alzheimer's disease: a Two-Sample Mendelian Randomisation Study

Si Han,Tom Lelieveldt,Miriam CJM Sturkenboom,Geert Jan Biessels,Fariba Ahmadizar

DOI: https://doi.org/10.1101/2024.12.19.24319309

2024-12-20

Abstract:Aims Type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) are significant global health issues. Epidemiological studies suggest T2DM increases AD risk, though confounding factors and reverse causality complicate this association. This study aims to clarify the causal relationship between T2DM and AD through a systematic review and meta-analysis of Mendelian randomization (MR) studies and a new two-sample MR analysis. Materials and Methods A literature search across major databases was conducted through May 2024 to identify MR studies linking T2DM and AD. Fixed/random-effect models provided pooled odds ratios (OR) with 95% confidence intervals (CI), and heterogeneity was assessed with the I^2 statistic. For our MR analysis, we pooled genetic variants from selected studies and analyzed AD outcomes using IGAP, EADB, and UKB databases. Multiple MR methods, including inverse-variance weighted (IVW) and pleiotropy-robust approaches, were applied for validation. Results Of 271 articles, eight MR studies were included (sample sizes: 68,905 to 788,989), all from European ancestry. Our meta-analysis found no significant causal link between T2DM and AD (OR = 1.01, 95% CI: 0.99-1.03) with moderate heterogeneity (I^2 = 44.16%). Similarly, our MR analysis using 511 SNPs as instrumental variables showed no significant associations in IGAP, EADB, or UKB data, consistent across sensitivity analyses. Conclusions This meta-MR and MR analysis revealed no significant causal association between T2DM and AD, indicating that T2DM may not directly influence AD risk. Further research should explore other mechanisms linking these conditions.